Liberty BioSecurity
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact
Access Octomono Masonry Settings

Media

Expeditionary Science and Special Programs Laboratory

6/17/2019

 
Liberty’s Expeditionary Science and Special Programs Laboratory (X-Lab) develops bioengineering and clinical solutions to challenging medical, commercial and industrial unmet needs. These solutions are derived from novel organisms obtained from government and Liberty's own proprietary collection of extremophile biologics. The X-Lab's multidisciplinary team of microbiologists and bioinformaticians are supported by physicians and experts drawn from military and intelligence communities.
Bioengineering lead candidate (LJ-321)
​

One novel species, designated as LJ-321, is capable of surviving sustained exposure to high-doses of UV radiation that otherwise destroy the DNA of species on Earth. X-Lab scientists have forced directed evolution of LJ-321 to produce UV-resistant compounds. These compounds are being characterized for UV-blocking biological capabilities for use in hydrogels, paints, plastics, and other industrial and commercial materials.

Clinical lead candidate (L-211)

The Expeditionary Science and Special Programs Laboratory is developing another novel organism, designated as LP-888, that secretes a compound that inhibits bacterial efflux pumps. Efflux pumps serve as the principal pathway used by bacteria to develop resistance to antibiotics.
​
The compound produced by L-211 has been shown to reverse antibiotic resistance in a range of human pathogens, to include Methicillin-resistant Staphylococcus aureus (MRSA). L-211 is under investigation by the X-Lab as a co- therapeutic to antibiotics to enhance their effectiveness in defeating antibiotic resistant strains of bacteria.

Comments are closed.

    Categories

    All
    Interviews
    Press Releases
    Publications
    Videos
    White Papers

    Archives

    February 2021
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    April 2019
    November 2018
    October 2018
    August 2018
    May 2018
    April 2018
    March 2018

Home
Our Team
Sciences
Media
Careers

Contact​
Established in 2014, Liberty Biosecurity is a privately-owned entity that in 2016 became a proud founding member of the EdenRoc Sciences family of life sciences companies and investments. Liberty Biosecurity Pty Ltd (Australia) was founded in 2016 and is registered under ABN 42612486325
  • Home
  • Our Team
  • Sciences
    • Novel Biology >
      • Isolate Program
    • Bioinformatics
  • Media
  • Careers
  • Contact